Intended Use |
Summary |
Principle |
Warnings and Precautions |
Composition |
Storage and Stability |
Additional Special Equipment |
Specimen |
Test Procedure |
Interpretation of Results |
Quality Control |
Limitations |
Performance Characteristics | ||
Accuracy | ||
Test | Compounds Contributed to the Totals of GC/MS |
THC | 11-nor-∆9-tetrahydrocannabinol-9-carboxylic acid |
%Agreement with Commercial Kit | %Agreement with GC/MS | |||
THC | THC | |||
Positive Agreement |
100% | Positive Agreement |
96% | |
Negative Agreement |
100% | Negative Agreement |
92% | |
Total Results |
100% | Total Results |
94% |
Precision |
11-nor-Δ9-THC- 9 COOH conc.(ng/ml) |
n per site | Site A | Site B | Site C | |||
- | + | - | + | - | + | ||
0 | 15 | 15 | 0 | 15 | 0 | 15 | 0 |
25 | 15 | 15 | 0 | 15 | 0 | 15 | 0 |
37.5 | 15 | 14 | 1 | 12 | 3 | 13 | 2 |
62.5 | 15 | 1 | 14 | 0 | 15 | 0 | 15 |
75 | 15 | 0 | 15 | 0 | 15 | 0 | 15 |
Analytical Sensitivity |
Drug concentration Cut-off Range |
n | THC | |
- | + | ||
0% Cut-off | 30 | 30 | 0 |
-50% Cut-off | 30 | 30 | 0 |
-25% Cut-off | 30 | 16 | 14 |
Cut-off | 30 | 2 | 28 |
25% Cut-off | 30 | 1 | 29 |
Analytical Specificity |
Marijuana (THC) | Concentration(ng/ml) |
11-nor-∆9-THC-9 COOH | 50 |
Cannabinol | 20,000 |
11-nor-∆8-THC-9 COOH | 30 |
∆8-THC | 15,000 |
∆9-THC | 15,000 |
Effect of Urinary Specific Gravity |
Effect of the Urinary pH |
Cross-Reactivity |
Non Cross-Reacting Compounds |
Acetaminophen | Acetophenetidin |
N-Acetylprocainamide | Acetylsalicylic acid |
Aminopyrine | Amoxicillin |
Ampicillin | L-Ascorbic acid |
Apomorphine | Aspartame |
Atropine | Benzilic acid |
Benzoic acid | Benzphetamine* |
Bilirubin | D/L-Brompheniramine |
Caffeine | Cannabidol |
Chloralhydrate | Chloramphenicol |
Chlorothiazide | D/L-Chloropheniramine |
Chlorpromazine | Chloroquine |
Cholesterol | Clonidine |
Cortisone | L-Cotinine |
Creatinine | Deoxycorticosterone |
Dextromethorphan | Diclofenac |
Diflunisal | Digoxin |
Diphenhydramine | Ecgonine methyl ester |
L -Ψ-Ephedrine | β-Estradiol |
Estrone-3-sulfate | Ethyl-p-aminobenzoate |
[1R,2S] (-) Ephedrine | L(–)-Epinephrine |
Erythromycin | Fenoprofen |
Furosemide | Gentisic acid |
Hemoglobin | Hydralazine |
Hydrochlorothiazide | Hydrocortisone |
O-Hydorxyhippuric acid | p-Hydroxyamphetamine |
p-Hydroxytyramine | Ibuprofen |
Iproniazid | D/L-Isoproterenol |
Isoxsuprine | Ketamine |
Ketoprofen | Labetalol |
Loperamide | Meperidine |
Meprobamate | Methoxyphenamine |
Methylphenidate | Nalidixic acid |
Naloxone | Naltrexone |
Naproxen | Niacinamide |
Nifedipine | Norethindrone |
D-Norpropoxyphene | Noscapine |
D/L-Octopamine | Oxalic acid |
Oxolinic acid | Oxymetazoline |
Papaverine | Penicillin-G |
Pentazocine hydrochloride | Perphenazine |
Phenelzine | Trans-2-phenylcyclo-propylamine hydrochloride |
L-Phenylephrine | β-Phenylethylamine |
Phenylpropanolamine | Prednisolone |
Prednisone | D/L-Propranolol |
D-Propoxyphene | D-Pseudoephedrine |
Quinacrine | Quinine |
Quindine | Ranitidine |
Salicylic acid | Serotonin |
Sulfamethazine | Sulindac |
Tetracycline | Tetrahydrocortisone 3-acetate |
Tetrahydrozoline | Tetrahydrocortisone 3 (β-D-glucuronide) |
Thiamine | Thioridazine |
D/L-Tyrosine | Tolbutamide |
Triamterene | Trifluoperazine |
Trimethoprim | Tryptamine |
D/L-Tryptophan | Tyramine |
Uric acid | Verapamil |
Zomepirac |
Bibliography |
Index of Symbols | |||||
![]() |
Do not reuse | ![]() |
For in vitro diagnostic use only | ||
![]() |
Stored between 2-30℃ | ![]() |
Consult instruction for use | ||
![]() |
Caution | ![]() |
Lot number | ||
![]() |
Use by | ![]() |
Contains sufficient for tests | ||
![]() |
Keep away from sunlight | ![]() |
Keep dry | ||
![]() |
Manufacturer | ![]() |
Do not use if package is damaged | ||
![]() |
Authorized Representative in the European Community | ||||
Request Information |
Other Products |
Related Products |
Recently viewed products |